GOLDSMITH MARK A bought RVMD
November 12, 2025 · Form 4 insider transaction
GOLDSMITH MARK A bought 20,000 shares of Revolution Medicines, Inc. at $4.09 per share, a transaction worth $81.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$4.09
Total value
$81.8K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after267,863
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 193,475 restricted stock units.